Creo Medical (1RC) AI Stock Analysis

Creo Medical

(Stuttgart:1RC)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Manageable leverageRelatively low leverage gives Creo greater financial flexibility while it scales its medical-device platform. A sizable equity base can help absorb continued investment needs and reduces the immediate balance-sheet pressure associated with high debt servicing obligations.

Negative Factors

Persistent operating lossesLarge recurring operating losses show that the current cost base remains well ahead of revenue scale. Unless growth translates into meaningful operating leverage, Creo may continue needing substantial investment before its core activities can generate sustainable profitability.

Creo Medical (1RC) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 51.09M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -2.5
Beta (1Y): 1.07
Revenue Growth: ―
EPS Growth: ―
Country: Germany
Employees: 104
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Devices

Creo Medical Business Overview & Revenue Model

Company Description

Creo Medical Limited, a UK-based enterprise and subsidiary of Creo Medical Group plc, specializes in the innovation and creation of electrosurgical medical devices for surgical endoscopy applications. Founded in 2003 as MicroOncology Ltd and headquar...

Creo Medical Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:1RC against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
GB:TSTL	80Outperform	GBP 194.70M	24.28	23.05%	3.51%	10.02%	19.83%
GB:SN	72Outperform	GBP 9.27B	19.52	12.25%	2.66%	2.17%	27.33%
GB:AMS	67Neutral	GBP 611.34M	166.18	1.44%	1.66%	6.05%	-60.00%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
GB:SUN	40Underperform	GBP 3.73M	-4.00	-15.47%	―	-3.68%	20.00%

* Healthcare Sector Average

Performance Comparison

DE:1RC and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:1RC	Creo Medical	0.13	0.01	4.07%
GB:AMS	Advanced Medical Solutions	282.50	68.48	32.00%
GB:SUN	Surgical Innovations Group Plc	0.40	-0.18	-31.03%
GB:TSTL	Tristel plc	405.00	55.79	15.97%
GB:SN	Smith & Nephew (UK)	1107.50	-272.82	-19.76%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Creo Medical AI Stock Analysis